Bortezomib-based chemotherapy to treat refractory angioimmunoblastic T-cell lymphoma: A case report and review of the literature.

about

Bortezomib-based chemotherapy to treat refractory angioimmunoblastic T-cell lymphoma: A case report and review of the literature.

Item

http://www.wikidata.org/entity/Q36640837

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Bortezomib-based chemotherapy ...... and review of the literature.

@ast

Bortezomib-based chemotherapy ...... and review of the literature.

@en

type

Item

label

Bortezomib-based chemotherapy ...... and review of the literature.

@ast

Bortezomib-based chemotherapy ...... and review of the literature.

@en

prefLabel

Bortezomib-based chemotherapy ...... and review of the literature.

@ast

Bortezomib-based chemotherapy ...... and review of the literature.

@en

P1476

Bortezomib-based chemotherapy ...... and review of the literature.

@en

P2093

Hua-Ping DU

http://www.w3.org/2001/XMLSchema#string

Qian-Qian Yang

http://www.w3.org/2001/XMLSchema#string

Y E Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple myeloma

Treatment of Peripheral T-Cell Lymphoma: Many Shades of Gray

The aggressive peripheral T-cell lymphomas: 2013

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

A phase 2 study of bortezomib in relapsed, refractory myeloma.

Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma.

Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project.

Bortezomib salvage therapy in refractory acute adult T-cell leukemia/lymphoma.

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

P304

2310-2314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.4213

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

293807513

http://www.w3.org/2001/XMLSchema#string

P698

26998168

http://www.w3.org/2001/XMLSchema#string

P932

4774619

http://www.w3.org/2001/XMLSchema#string